WAKEFIELD, MA, Feb. 14 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. will hold a webcast at 4:30 p.m. EST on Wednesday February 15, 2006 regarding the company’s 2005 fourth quarter and year-end results.
In addition to standard disclosure over wire services, a news release and financial statements will be posted on the NUCRYST web site. To listen to the call live on the Internet, please go to www.nucryst.com.
Scott H. Gillis, President & CEO and Eliot M. Lurier, Vice President, Finance and Administration will participate on the call.
An audio file of the call will be archived and posted on the NUCRYST web site.
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using its patented nanocrystalline silver technology. Advanced wound care products with the company’s SILCRYST(TM) coatings are sold by Smith & Nephew plc under an exclusive license in over 30 countries under its Acticoat(TM) trademark. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation. The company has developed its nanocrystalline silver in a powder form for use as an active pharmaceutical ingredient, referred to as NPI 32101.
NUCRYST Pharmaceuticals Corp.
CONTACT: Gillian McArdle, (416) 504-8464, info@nucryst.com
